Overview

What is Benign Prostatic Hyperplasia (BPH)?

Benign Prostatic Hyperplasia (BPH), also known as prostate gland enlargement, is a common condition that occurs in aging men. It involves the non-cancerous growth of the prostate gland, which is situated below the bladder and surrounds the urethra (the tube that carries urine from the bladder out of the body).

Symptoms of Benign Prostatic Hyperplasia:

As men age, the prostate gland tends to enlarge, a process attributed to hormonal changes, particularly an increase in the production of dihydrotestosterone (DHT). The enlargement of the prostate can compress the urethra, leading to various urinary symptoms. Common signs and symptoms of BPH include:

  • Frequent or Urgent Urination: The need to go to the bathroom more frequently, particularly at night.
  • Difficulty Starting or Maintaining Urination: A weakened or interrupted urine stream or the sensation of incomplete emptying.
  • Increased Frequency of Urinary Tract Infections: Due to incomplete emptying of the bladder.
  • Hematuria: The presence of blood in the urine, though this is less common.

It's important to note that while these symptoms may be indicative of BPH, they can also be associated with other medical conditions. If you are experiencing any of these symptoms, it is advisable to seek medical evaluation and guidance for an accurate diagnosis and appropriate management.

Causes of Benign Prostatic Hyperplasia (BPH):

The exact cause of BPH is not fully understood, but it is primarily associated with aging and hormonal changes. The prostate gland tends to enlarge gradually as men age, and this enlargement is influenced by an increase in the production of dihydrotestosterone (DHT), a hormone derived from testosterone. Other factors that may contribute to the development of BPH include:

  • Family History: Having a family history of BPH may increase the likelihood of developing the condition.
  • Hormonal Changes: Aging is associated with changes in hormone levels, particularly an increase in DHT production.
  • Chronic Inflammation: Ongoing inflammation in the prostate gland may play a role in the development of BPH.

Diagnosis of Benign Prostatic Hyperplasia (BPH):

Diagnosing BPH typically involves a combination of medical history assessment, physical examination, and various diagnostic tests. Key components of the diagnostic process include:

  1. Medical History: A detailed discussion of symptoms, their duration, and their impact on daily life.
  2. Digital Rectal Exam (DRE): A physical examination in which a healthcare provider assesses the size, shape, and consistency of the prostate gland through the rectum.
  3. Prostate-Specific Antigen (PSA) Test: A blood test is used to gauge the prostate's production of the protein PSA. Increased PSA values can be a sign of BPH among other prostate conditions.
  4. Urinalysis: Examination of a urine sample to rule out urinary tract infections or other conditions causing similar symptoms.
  5. International Prostate Symptom Score (IPSS): A questionnaire assessing the severity of urinary symptoms.
  6. Uroflowmetry: Measurement of urine flow rate to evaluate the strength and consistency of the urine stream.
  7. Transrectal Ultrasound (TRUS): An imaging test using sound waves to create an image of the prostate, helping to assess its size and structure.
  8. Cystoscopy: A procedure involving a thin, flexible tube with a camera to examine the interior of the urethra and bladder.

Once a diagnosis is confirmed, the healthcare provider will determine the severity of symptoms and recommend an appropriate treatment plan tailored to the individual's needs.

Treatments for Benign Prostatic Hyperplasia (BPH):

The management of Benign Prostatic Hyperplasia (BPH) aims to alleviate symptoms and improve the quality of life. Treatment options vary based on the severity of symptoms, overall health, and patient preferences. Common approaches include:

  • Watchful Waiting or Active Surveillance: Monitoring the condition without immediate intervention, particularly in cases with mild symptoms or where symptoms are not significantly impacting daily life.
  • Lifestyle Modifications: Implementing changes such as limiting fluid intake before bedtime, avoiding caffeine and alcohol, and practicing timed voiding to manage urinary symptoms.
  • Medications:
    • Alpha-Blockers: Relax muscles in the prostate and bladder neck, improving urine flow.
    • 5-Alpha Reductase Inhibitors: Reduce the size of the prostate gland by inhibiting the production of dihydrotestosterone (DHT).
    • Combination Therapy: Using both alpha-blockers and 5-alpha reductase inhibitors for enhanced symptom relief.

Minimally Invasive Procedures:

  • Transurethral Microwave Thermotherapy (TUMT): Uses microwaves to heat and destroy excess prostate tissue.
  • Transurethral Needle Ablation (TUNA): Delivers radiofrequency energy to heat and shrink prostate tissue.
  • Transurethral Resection of the Prostate (TURP): Surgical removal of excess prostate tissue using a resectoscope inserted through the urethra.
  • Laser Therapy:
    • Laser Enucleation of the Prostate (HoLEP): Uses lasers to remove prostate tissue.
    • Photoselective Vaporization of the Prostate (PVP): Vaporizes excess prostate tissue.
  • Prostatic Urethral Lift (UroLift): Inserting implants to lift and hold the enlarged prostate tissue, relieves compression on the urethra.
  • Open Prostatectomy: Reserved for extremely enlarged prostates, involves the surgical removal of excess prostate tissue through an abdominal incision.

The choice of treatment depends on factors such as the severity of symptoms, the size of the prostate, overall health, and patient preferences. A healthcare provider will discuss the available options and tailor the treatment plan to address the specific needs of each individual.

Medication Information:

Alpha-blockers, such as tamsulosin (Flomax®), alfuzosin (Uroxatral®), and silodosin (Rapaflo®), are commonly used for the medical treatment of Benign Prostatic Hyperplasia (BPH). These medications work by reducing tension in the enlarged prostate, facilitating easier urine flow. Alpha-blockers are generally well-tolerated, with dizziness due to lowered blood pressure being a potential side effect.

If symptoms persist, medications like finasteride or dutasteride may be added to the treatment plan. These medications inhibit an intra-prostatic enzyme, promoting the shrinking of the prostate and reducing obstruction. Side effects may include a decrease in libido, breast tenderness, and, in some cases, erectile dysfunction.

Procedural Information - Prostatic Artery Embolization (PAE):

Prostate artery embolization (PAE) is a minimally invasive procedure for treating BPH, particularly for patients with moderate to severe urinary symptoms. During PAE, a specially trained interventional radiologist inserts a catheter into an artery in the leg or wrist, guiding it to the arteries supplying the prostate.

Thousands of microscopic beads are then delivered through the catheter to block blood flow to the prostate, leading to its gradual shrinkage and improvement in urinary symptoms. PAE is performed under local anesthesia with sedation, and recovery is usually quick.

Recovery from PAE:

  • PAE is a same-day outpatient procedure.
  • Recovery typically takes about two hours.
  • Discharge includes over-the-counter pain medications and a short course of antibiotics.
  • Normal activities can be resumed the next day.
  • Symptom relief often begins within a month, with continued improvement over six months.

Potential Side Effects:

  • Urinary tract infection: Rare, with antibiotics given during and after the procedure.
  • Increased urinary frequency, urgency, and burning: Lasting up to a week after the procedure.

Unlike traditional treatments, PAE is not typically associated with sexual/erectile dysfunction. Leading-edge imaging and catheter techniques minimize side effects related to sexual function. Many patients can cease BPH medications entirely following PAE treatment.

If you are experiencing BPH symptoms, consult with your healthcare provider to discuss appropriate medication or procedural options tailored to your individual needs.

Discover the Advantages of Prostate Artery Embolization with Dr. Mohamed Hosni:

Schedule a consultation with Dr. Mohamed Hosni, an esteemed interventional radiologist at Cedars-Sinai, to explore the benefits of Prostate Artery Embolization. Dr. Hosni's expertise ensures personalized and impactful care, with a focus on your well-being and the restoration of comfort in your daily life.

Embark on the path to relief by securing. Your journey towards enhanced prostate health and an improved quality of life begins right here. Arrange your consultation now to delve into the innovative options available to you.

Secure Your Appointment Today